Nilsine Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $209K | Sell |
4,524
-1,227
| -21% | -$56.8K | 0.02% | 367 |
|
|
2025
Q1 | $351K | Sell |
5,751
-568
| -9% | -$34.6K | 0.04% | 280 |
|
|
2024
Q4 | $357K | Buy |
+6,319
| New | +$357K | 0.04% | 294 |
|
|
2024
Q2 | – | Sell |
-9,739
| Closed | -$528K | – | 324 |
|
|
2024
Q1 | $528K | Sell |
9,739
-451
| -4% | -$24.5K | 0.07% | 226 |
|
|
2023
Q4 | $523K | Sell |
10,190
-242
| -2% | -$12.4K | 0.08% | 217 |
|
|
2023
Q3 | $605K | Sell |
10,432
-548
| -5% | -$31.8K | 0.09% | 202 |
|
|
2023
Q2 | $702K | Buy |
10,980
+418
| +4% | +$26.7K | 0.1% | 193 |
|
|
2023
Q1 | $732K | Buy |
+10,562
| New | +$732K | 0.11% | 188 |
|